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The choroid plexus secretes cerebrospinal ﬂuid and is critical for the development and
function of the brain. In the telencephalon, the choroid plexus epithelium arises from the
Wnt- expressing cortical hem. Canonical Wnt signaling pathway molecules such as nuclear
β-CATENIN are expressed in the mouse and human embryonic choroid plexus epithelium
indicating that this pathway is active. Point mutations in human β-CATENIN are known to
result in the constitutive activation of canonical Wnt signaling. In a mouse model that
recapitulates this perturbation, we report a loss of choroid plexus epithelial identity and an
apparent transformation of this tissue to a neuronal identity. Aspects of this phenomenon are
recapitulated in human embryonic stem cell derived organoids. The choroid plexus is also
disrupted when β-Catenin is conditionally inactivated. Together, our results indicate that
canonical Wnt signaling is required in a precise and regulated manner for normal choroid
plexus development in the mammalian brain.
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he Choroid plexus (ChP) produces cerebrospinal ﬂuid
(CSF) which plays an important role in the developing and
adult brain. The CSF provides protective functions, such as
cushioning against mechanical damage, nutritive function, and
signaling functions, providing molecular cues for the developing
brain1,2. The ChP separates the blood from the CSF creating a
checkpoint for regulating the entry and exit of factors2,3. The ChP
is also the gateway for immune cells entering or exiting the
brain4.
The ChP epithelium (ChPe) arises from adjacent neuroepithelial tissue in the telencephalon, diencephalon, and hindbrain.
In the telencephalon, the non-neuronal ChPe and a subpopulation of Cajal-Retzius (CR) neurons both arise from the
cortical hem5–7, a midline telencephalic signaling center enriched
in genes that belong to the BMP and WNT protein families. The
telencephalic hem has been identiﬁed in several vertebrate
classes8. In the opossum Monodelphis domestica, BrdU positive
cells arise from the hem and populate the growing telencephalic
ChPe in a “conveyor belt” like manner9. Consistent with this
model, when the size of the cortical hem increases10, decreases11
or is missing altogether12, there is a parallel change in the extent
of the ChP.
The mechanisms that regulate the speciﬁcation of the ChPe are
important from developmental, disease, and evolutionary perspectives. Obvious candidates for the control of ChPe development are the signaling molecules expressed in the neuroepithelial
progenitor domains. The hem expresses several members of the
Bmp and Wnt families12,13. When the expression of these signaling molecules in the hem is compromised, such as in the Gli3
null (XtJ) mutant, neither the ChP nor the hippocampus is speciﬁed normally12,14. Bmp signaling is critical for ChPe speciﬁcation. The ChP is missing in the BmpR1a null mutant
mouse15,16, and Bmp4 is sufﬁcient for ChPe induction
in vitro16,17. The role of hem-derived Wnt ligands in ChPe
development appears to be equally important, though not well
explored. Wnt5a, expressed in the hem, appears to be required for
maintaining the size and the cytoarchitecture of the ChPe18. A
role for canonical Wnt signaling in ChPe development is suggested by the observation that the choroid plexus appears to be
reduced in the Wnt3a null mutant19. Furthermore, the addition
of WNT3A augments the ChPe-inducing ability of BMP4 in a
three-dimensional aggregation culture derived from embryonic
stem cells (ESCs)17.
In this study, we demonstrate that molecules downstream of
canonical Wnt signaling, such as nuclear β-CATENIN
(CTNNB1), are present in vivo at embryonic stages in the
human and mouse ChPe. Mutations in particular domains of
human β-CATENIN have been reported to cause constitutive
activation of this pathway since they interfere with β-CATENIN
phosphorylation and consequent degradation20. Speciﬁcally, exon
3 of the β-CATENIN gene is a hotspot for several mutations,
including point mutations and deletions associated with various
forms of cancer21. The effects of these mutations on ChP-related
disorders have not been studied, even though ChP papillomas
have been reported to display upregulation of canonical Wnt
signaling22. Therefore, we focused our studies on examining the
effects of constitutive activation of β-CATENIN in the mouse
ChPe using a strategy in which exon 3 can be conditionally
deleted. We discovered that this perturbation causes a loss of
ChPe identity and, surprisingly, a gain of neuronal identity,
together with comprehensive transcriptomic changes that are
consistent with the activation of canonical Wnt signaling. We
paralleled these studies in a human ESC (hESC)- derived organoid model in which treatment with a low level of a canonical
Wnt agonist together with BMP4 resulted in a ChPe-like fate, but
over-activation with high levels of the Wnt agonist recapitulated
2

the loss of ChPe identity seen in the mouse. Loss of β-catenin in
the mouse resulting in an absence of canonical Wnt signaling23
also disrupted ChPe development.
Together, our results indicate that controlled levels of canonical
Wnt signaling is critical for ChPe speciﬁcation and morphogenesis and that this mechanism appears to be conserved in humans
and rodents.
Results
The human fetal ChPe and the embryonic mouse ChPe display
components of canonical Wnt signaling. We examined whether
the molecular machinery required for processing canonical Wnt
signaling is present in the developing ChPe at the relevant stages
in both human and mouse embryos. In humans, the telencephalic
ChP develops between gestational weeks 8 to 12. We collected
human fetal samples from GW11 and GW13 and performed
immunohistochemical analysis for Wnt signaling components.
The human ChP is identiﬁed by its fan-like morphology within
the telencephalic ventricles (Fig. 1a, b), and the presence of AQP1
and OTX2 that are established ChPe markers (Fig. 1a–g). The
canonical Wnt receptor, FZD1, is detected throughout the ChPe
(Fig. 1b). LEF1, AXIN2, and β-CATENIN are also present, consistent with canonical Wnt signaling. In particular, β-CATENIN
was detected in the nucleus, (Fig. 1d, e) indicating that canonical
Wnt signaling is likely to be active in the human ChPe at early
stages during ChP development.
In the embryonic day E12.5 mouse, the hem and the ChPe are
identiﬁed by the expression of Wnt3a and the thyroid hormone
T4 carrier transthyretin (Ttr), respectively (Fig. 1h). The
expression of several canonical Wnt signaling pathway molecules
was detected in the ChPe including receptors such as Frizzled 1
and 2a (Fzd1, Fzd2a), a target gene Axin2, and the transcriptional
regulators β-CATENIN and LEF1 were present in nuclei of ChPe
cells (Fig. 1i–k). These data suggest that the embryonic human
and mouse ChPe have the capability of processing canonical Wnt
signaling.
Disrupting β-CATENIN function in the hem and ChPe. Lmx1a
expression is speciﬁc to the hem and the ChPe within the
telencephalon24. To genetically manipulate the developing ChPe we
used the Lmx1aCre line, which faithfully labels the hem lineage that
is composed of Cajal-Retzius cells and ChPe cells, when crossed to
the Ai9 reporter line25 (Fig. 2a). Therefore, the Lmx1aCre line
offers the opportunity of disrupting genetic mechanisms not only
in the ChPe, but also in its domain of origin, the hem.
We used Lmx1aCre together with two well-described mouse
lines to introduce either gain-of-function (GOF) or loss-offunction (LOF) genetic perturbations in the β-catenin (Ctnnb1)
gene. In β-catenin GOF mice, exon 3 of β-catenin is ﬂanked by
loxP sites, and Cre-mediated recombination results in deletion of
a domain that contains phosphorylation sites for GSK3β, which
would normally tag β-CATENIN for degradation. The recombined β-catenin allele encodes a protein that remains constitutively active26 (gain of function). This results in increased
accumulation of active β-CATENIN within the nucleus of ChPe
cells consistent with its role as a transcription factor27. Intensity
quantiﬁcation of the immunoﬂuorescence within the nuclei of
ChPe cells revealed that GOF mice have higher levels of active
nuclear β-CATENIN than controls (Fig. 2b, c).
We examined whether these perturbations resulted in transcriptional changes that are typical of canonical Wnt pathway
activity. We microdissected the ChP from E14.5 control and βcatenin GOF embryos, using the expression of the Ai9 reporter
(Fig. 2d). This gave us a relatively pure ChP preparation that was
processed for bulk RNA-seq. 2439 genes were downregulated and
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Fig. 1 Canonical Wnt signaling components are present in the developing human and mouse choroid plexus epithelium. a–g Canonical Wnt signaling
pathway molecules FZD1, β-CATENIN, LEF1, and AXIN2, and also ChPe markers OTX2 and AQP1 are detected at gestational week (GW) 11 (b–e) and
GW13 (f, g) in the human choroid plexus epithelium. d, e β-CATENIN immunohistochemistry intensity measurements across three ChPe cells (identiﬁed
by colored arrowheads in d corresponding to traces in e). β-CATENIN intensity is seen in the nucleus, indicative of active canonical Wnt signaling and the
boundaries between cells. b–g Representative images of sections taken from 1 fetal brain at each age. h In the E12.5 mouse telencephalon, Wnt3a and Ttr
expression identiﬁes the hem the ChPe, respectively. i, j Nuclear localization of β-CATENIN and its quantitation (Bkgd, background; scatterplot represents
mean ± SEM; n = 150 nuclei; N = 3 brains (biologically independent replicates) examined over 3 independent experiments. k Canonical Wnt signaling
components Axin2, Fzd1, Fzd2a, and LEF1 are expressed in the E12.5 mouse ChPe. (h, k) Representative images of sections taken from N = 7 brains
(biologically independent replicates) examined in 5 independent experiments. Statistical test (j): One Way ANOVA followed by post hoc Dunnett’s
multiple comparison test (p < 0.0001), *p < 0.05, **p < 0.01, ***p < 0.001, ns if p value > 0.05. Scale bars: 500 μm (all panels in b and f); 50 μm (all panels
in d, i low mag, g, h, and k); 10 μm (d and i high mag). Boxed regions (b, c, d, f, i) are shown at high magniﬁcation in the adjacent panels. Further
information on replicates and reproducibility for this ﬁgure is mentioned in the “Statistics and Reproducibility” section of the Methods. Source data are
provided as a Source Data ﬁle.
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Fig. 2 Stabilization of β-CATENIN leads to activation of canonical Wnt signaling. (a) At E12.5, in situ hybridization for Lmx1a shows endogenous
expression; the Ai9 reporter labels the Lmx1a-expressing lineage, including the hem, ChPe, and hem-derived Cajal-Retzius cells. (b, c) At E14.5, nuclear
localization of active (non-phosphorylated) β-CATENIN is increased in the Lmx1aCre::β-cat GOF ChPe compared with controls (arrowheads) as seen by (b)
immunohistochemistry and (c) a violin plot representing quantitation of n = 294 nuclei (control) and n = 301 (GOF); N = 3 brains (biologically independent
replicates) for each genotype examined over 2 separate experiments. Boxed regions (b) are shown at high magniﬁcation in the adjacent panels. (d)
Microdissection of E14.5 Ai9-labeled telencephalic hemispheres to isolate ChP (inset) for RNA extraction. (a, d) Representative images of sections taken
from N = 3 brains (biologically independent replicates) examined over 2 independent experiments. (e) Heatmap (showing normalized reads) of Wnt
signaling target genes from RNA-seq data from control and Lmx1aCre::β-Catenin GOF ChP (N = 2 biologically independent replicates). Color key: red (high
expression) and blue (low expression) (f–i) In situ hybridization (Axin2), qPCR Axin2 and Lef1, and immunohistochemistry (AXIN2, LEF1, and SOX9) reveal
upregulation of AXIN2 and LEF1 and downregulation of SOX9 in the Lmx1aCre::β-cat GOF ChPe compared with controls. (f, h) Representative images of
sections taken from N = 3 brains (biologically independent replicates) examined over 2 independent experiments. Bar graphs (g) represent mean ± SEM,
N = 3 brains (biologically independent replicates) for each genotype examined over 2 independent experiments. (i) Violin plots quantifying the nuclear
intensity of LEF1 and SOX9, for LEF1: n = 505 nuclei for control and 500 nuclei for Lmx1aCre::β-cat GOF ChPe, N = 5 brains (biologically independent
replicates) for each genotype examined over 3 independent experiments; color key: dark blue (grey value =0) and white (grey value =255). For SOX9,
n = 457 nuclei for control and 444 nuclei for Lmx1aCre::β-cat GOF ChPe; N = 4 brains (biologically independent replicates) examined over 2 independent
experiments. For violin plots (c, i) solid black line represents median and dotted lines represent quartiles). Statistical tests: Two-tailed unpaired Student’s t
test with unequal variance (c, g), p < 0.0001 (c), p = 0.0005 (g, Lef1) and p = 0.0003 (g, Axin2); two-tailed unpaired multiple Student’s t test with unequal
variance (i), p < 0.000001 (i, LEF1 and SOX9). *p < 0.05, **p < 0.01, ***p < 0.001, ns if p value > 0.05. Scale bars: 10 μm (all panels in a, b, f and h); 100 μm
(all panels in d). Source data are provided as a Source Data ﬁle.

2163 genes upregulated in the ChP upon constitutive activation of
β-CATENIN, using a 1.5-fold cutoff (p.adj < 0.05; Supplementary
Table 1). KEGG pathway analysis identiﬁed the Wnt pathway as
one of the major pathways dysregulated in the Lmx1aCre::βcatenin GOF ChP (Supplementary Fig. S1). Consistent with this,
multiple canonical Wnt pathway targets were positively regulated
(Ccnd1, Cdx1, Cldn1, c-Myc, Dkk2, Jun, Lef1, Met, Mycbp2,
Neurod1, Pitx2, Sfrp2, Sox17, Tcf1, Wif1, Wnt4), and others were
negatively regulated (Sostdc1, Sox9,) (Fig. 2e; Supplementary
Fig. S1;28,29, https://web.stanford.edu/group/nusselab/cgi-bin/
wnt/target_genes). We further examined well-established positively regulated targets of this pathway, Axin2, Lef1, and a
negatively regulated target Sox9, by in situ hybridization, qPCR,
and/or immunohistochemistry, in the control and Lmx1aCre::βcatenin GOF ChPe. Both mRNA and protein for Axin2/ AXIN2
and Lef1/ LEF1 showed a marked increase in the GOF ChPe
compared with controls. In contrast, SOX9, which is normally
present in the ChPe, is greatly reduced in the β-catenin GOF
ChPe, consistent with its suppression by canonical Wnt
signaling30 (Fig. 2f–i).
4

We also examined the loss of function of β-CATENIN using
Lmx1aCre using a well-described mouse line in which exon 2- 6
of the ß-catenin gene encoding a portion of the armadillo repeat
region is removed by Cre-mediated recombination, resulting in a
non-functional, transcriptionally inactive protein23,31. In the
Lmx1aCre::β-catenin LOF ChPe cell nuclei, the levels of nonphosphorylated (active) β-CATENIN are nearly undetectable
(Supplementary Fig. S2a, b). Nuclear LEF1 protein levels
decreased compared with controls (Supplementary Fig. S2c, d).
Furthermore, while TTR is present throughout the LOF ChPe at
E16.5 and at birth (Supplementary Fig. S2e, f), AQP1 is
undetectable in several cells, suggesting a functional disruption
of the ChPe (Supplementary Fig. S2g, h).
β-CATENIN plays an important role in cell adhesion in
addition to its function in transcriptional regulation. Consistent
with this, both the GOF and LOF perturbations of β-CATENIN
caused the ChPe to exhibit an abnormal morphology. The βcatenin GOF ChP was extensively folded, accompanied by a
highly disorganized E-CADHERIN distribution (Supplementary
Fig. S3a, b). In the β-catenin LOF ChP, even though the exons
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2–6 that are deleted in the LOF allele are critical for its role in cell
adhesion, the labeling pattern of E-CADHERIN appeared
unaltered at E12.5. However, by birth, E-CADHERIN distribution was disorganized together with dysmorphia of the ChP,
indicating that the loss of β-CATENIN may have a progressive
effect on ChP morphogenesis with time in development
(Supplementary Fig. S3c, d).
In summary, both GOF and LOF perturbations of β-CATENIN
cause disruptions of the canonical Wnt pathway, with additional
consequences on ChP morphology that are consistent with its
role in cell adhesion. The level of nuclear β-CATENIN increased
in the GOF and decreased in the LOF ChPe, and canonical Wnt
targets displayed the expected effects as a result of these
perturbations. We focused our subsequent analysis on the
Lmx1aCre::β-catenin GOF ChPe in the mouse to examine the
consequences of persistent activation of canonical Wnt signaling
since this perturbation is similar to the observed pathological
mutations in human β-CATENIN20,21. In a similar fashion, we
also studied the effects of activated canonical Wnt signaling in
hESC-derived organoids.
Constitutively activated β-CATENIN causes a loss of ChPe
identity. To study the effect of constitutive activation of βCATENIN on ChP development, we ﬁrst examined an age series
and found a progressive loss of Ttr expression in the Lmx1aCre::β-catenin GOF ChPe from E12.5 to birth (Fig. 3a, b).
Immunostaining for apically enriched ACTIN and basal lamina
marker LAMININ revealed major morphological changes from
E14.5 in the form of multiple folds (Fig. 3c–e). Although OTX2, a
transcription factor critical for ChPe development, was detected
in 93.2% of the GOF ChPe cells (compared with 98.2% in the
control), quantiﬁcations indicated that its level was drastically
reduced in the GOF ChPe (Fig. 3f, g). AQP1 and TTR staining
were undetectable in the vast majority of GOF ChPe cells, with
only 2.3% or 12.4% cells positive for AQP1 or TTR, respectively,
compared with 93.6 and 97.8%, respectively, in the controls
(Fig. 3f, h). The ventricles of Lmx1aCre::β-catenin GOF brains
collapsed as development proceeded (Fig. 3a), possibly due to a
lack of ﬂuid resulting from reduced AQP1 together with a
reduction in several solute transporters encoded by the SLC
family (SLC12a2, 4a2, 4a10; Fig. 3i, j). The progressive nature of
the phenotype is consistent with the constitutive and persistent
nature of the GOF disruption of the β-Catenin gene.
Gain of neuronal identity in the ChPe upon constitutive activation of β-CATENIN. The loss of ChPe markers in Lmx1aCre::β-catenin GOF brains prompted us to examine whether this
tissue acquired a different identity. It is well established that
canonical Wnt signaling from the cortical hem is necessary and
sufﬁcient for the induction of hippocampal fate in the adjacent
neuroepithelium32–34. Therefore, we tested whether neuronal,
and in particular hippocampal markers were upregulated in the
Lmx1aCre::β-catenin GOF ChPe. Remarkably, at E13.5, parts of
the GOF ChPe were positive for both the ChPe marker OTX2,
and PAX6 which is normally restricted to neuronal ventricular
zone progenitors (Fig. 4a; Supplementary Fig. S4). Likewise,
several cells were positive for OTX2 as well as the dentate granule
cell marker PROX1. Overall, 31.9% OTX2 + cells were PAX6 +
and 20.3% were PROX1 + in the β-catenin GOF ChPe, compared
with no co-labeling (0%) for each of these markers in controls
(Fig. 4a–c). The β-catenin GOF also displays enhanced proliferation as seen by PH3 labeling, and apoptosis as detected by
staining for cleaved CASPASE 3 (Supplementary Fig. S4).
By E16.5, 41% of Cre-expressing (Ai9) cells were positive for
PROX1 (Fig. 4d, e) in Lmx1aCre::β-catenin GOF brains
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compared with 0% in the controls. As development proceeds,
the telencephalic ventricular zone progenitors give rise to a TBR2positive pool of sub-ventricular zone progenitors. At E16.5, the
GOF ChPe displayed this feature as well, such that numerous
(39.8%) TBR2-positive cells were scattered in this tissue, but were
never seen in controls (Fig. 4d, e). In addition, the postmitotic
neuronal marker βIII TUBULIN appeared in 58% of the Ai9+
cells in the GOF ChPe compared with 0% in controls (Fig. 4d, e).
The ChP is normally populated by a small number of scattered
neuronal cells35, which also appeared in the control sections we
examined. However, these do not arise from the hem and did not
express Ai9, whereas the TBR2 and βIII TUBULIN positive cells
in the GOF ChPe co-localized with Ai9 (Supplementary Fig. S5).
PROX1 labeling persisted in the Lmx1aCre::β-catenin GOF at
E18.5. While PROX1 was never detected in the controls, it was
present in varying intensities in the cells of the GOF ChPe in
which OTX2 levels were uniformly low compared with controls
(Fig. 4f–i).
Lmx1aCre acts in the progenitor domain for the ChPe, the
cortical hem, as well as in the differentiated ChPe25. We
compared this line with Foxj1Cre, which acts in ciliated cells in
the brain, and is known to be expressed in the primordial ChPe
from E11.536,37. When each Cre line was crossed to the Ai9
reporter, the differences in their expression domain were
apparent: Foxj1Cre did not appear to be active at E10.5, at which
stage Lmx1aCre was expressed in the hem and in the choroid
plaque (arrowheads, Fig. 5a, b), which is the precursor of
differentiated ChPe. At E12.5, Foxj1Cre was expressed in the
ChPe and by Cajal-Retzius cells, but excluded from the hem,
whereas Lmx1aCre was expressed in all these structures (Fig. 5a,
b). Foxj1Cre::β-catenin GOF embryos displayed a dysmorphic
ChP that recapitulated the loss of ChPe identity seen in
Lmx1aCre::β-catenin GOF brains (Fig. 5). At E16.5, only 33.3%
of the Ai9 cells were also AQP1-positive and 47% were TTR
positive, compared with 98.25 and 98.47%, respectively, in the
controls. While OTX2 labeling persisted in the Foxj1Cre::βcatenin GOF ChPe, its level was signiﬁcantly lower than in
controls (Fig. 5c–e), mirroring that seen in Lmx1aCre::β-catenin
GOF brains. These changes were apparent throughout the rostrocaudal extent of the Foxj1Cre::β-catenin GOF ChPe (Supplementary Fig. S6). Therefore, the loss of ChPe identity in the
Foxj1Cre::β-catenin GOF ChPe recapitulated that seen in the
Lmx1aCre::β-catenin GOF ChPe.
In contrast, the Foxj1Cre::β-catenin GOF ChPe failed to
display any transformation to a neuronal fate. None of the
markers we reported in the Lmx1aCre::β-catenin GOF ChPe, i.e.,
PROX1, PAX6, TBR2, or βIII TUBULIN, were detected in the
Foxj1Cre::β-catenin GOF ChPe (Fig. 5f). This offers an insight
into the timing and stage at which the canonical Wnt pathway
can modulate neuronal fate speciﬁcation in cell types that
normally take on ChPe fate.
Since the loss of ChPe identity was accompanied by a gain of
neuronal identity only when the β-catenin GOF was initiated in
the hem, it was important to examine whether ChPe progenitors
were converted to neuronal progenitors or whether speciﬁed
ChPe cells that displayed ChPe markers were transformed to a
neuronal fate. Therefore, we examined whether neuronal markers
appear in cells that also display ChPe markers. At E12.5, both
control and Lmx1aCre::β-catenin GOF brains displayed Wnt2b
and BLBP restricted to the hem while Ttr mRNA and TTR
protein was restricted to the ChPe (Fig. 6a, b). Whereas βIII
TUBULIN staining was almost undetectable in control ChPe, a
small region of the β-catenin GOF ChPe was βIII TUBULIN
positive, co-localizing with TTR immunostaining (Fig. 6c). This
indicated that neuronal markers were upregulated in speciﬁed
ChPe cells from early stages in its development.
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To examine this neuronal transformation further, we took
advantage of X-inactivation-based mosaic expression of the Cre
recombinase in Lmx1aCre female embryos. Whereas male brains
expressed the Ai9 reporter in the entire Lmx1a expression
domain (Fig. 6d, f), female Lmx1aCre brains displayed a mosaic
expression of the Ai9 reporter (Fig. 6e, g), in both control
(Lmx1aCre::Ai9) and Lmx1aCre::Ai9::β-catenin GOF animals. In
control female brains, all ChPe cells, whether Ai9 positive and
6

negative, were TTR positive but did not display detectable βIII
TUBULIN immunoﬂuorescence (Fig. 6e, h). In β-catenin GOF
female brains, ChPe cells that were Ai9-negative (no Cre activity)
were indistinguishable from controls (Fig. 6g, j). Consistent with
the ﬁndings in male β-catenin GOF brains, some Ai9-positive
(Cre-active) cells in the ChPe of female β-catenin GOF brains
displayed βIII TUBULIN immunoﬂuorescence in cells that were
also TTR positive (Fig. 6g, l). Similar results were seen when ChPe
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Fig. 3 Constitutively active β-CATENIN in the hem and ChPe disrupts choroid plexus identity. a, b In situ hybridization for Ttr reveals a patchy
expression (arrowheads) that is progressively lost from E12.5-P0 in Lmx1aCre::β-cat GOF brains compared with controls. b Quantiﬁcation of Ttr-expressing
area ± SEM, N = 4 (E12.5); N = 5 (E13.5/E14.5), N = 4 (E15.5/E16.5), N = 3 (P0) brains (biologically independent replicates) examined over 3 independent
experiments. c, d Immunohistochemistry for ACTIN and LAMININ reveals that the ChP is extensively folded in Lmx1aCre::β-cat GOF brains compared with
controls. e Quantiﬁcation of the number of folds, N = 7 brains (biologically independent replicates) examined over 5 independent experiments. f ChPe
markers, such as AQP1 and TTR are almost undetectable, and OTX2 labeling is greatly reduced in intensity in the Lmx1aCre::β-catenin GOF compared with
controls. Boxed regions (f) are shown at high magniﬁcation in the adjacent panels. g Violin plot of OTX2 intensity/nuclear area reveals a signiﬁcant
reduction in the Lmx1aCre::β-cat GOF choroid plexus, n = 150 nuclei, N = 3 brains (biologically independent replicates) examined over 2 independent
experiments. h Scatter plot corresponding to 500 DAPI + cells scored for the co-labeling for each choroid speciﬁc marker. In the control brains 98.2% cells
are OTX2 + , 93.6% cells are AQP1 + , and 97.8% cells are TTR + whereas In Lmx1aCre::β-cat GOF ChPe 93.2% cells are OTX2 + , 2.3% cells are AQP1 + ,
and 12.4% cells are TTR + , N = 3 (g), N = 5 (h) brains (biologically independent replicates) examined over 3 separate experiments). i A cartoon
illustrating transporters that are downregulated in the ChPe of β-cat GOF brains. j qPCR analysis of E14.5 ChP shows that not only Ttr and Otx2 but also
several transporters and channels such as Aqp1, Scl12a2 (Nkcc1), Slc4a10 (NBCn2), Slc4a2 (Ae2) are signiﬁcantly downregulated in the Lmx1aCre::β-cat GOF
ChP compared with control, N = 3 brains (biologically independent replicates) examined over 2 independent experiments. Solid black line represents
median and dotted lines represents quartiles (g), bars (b, e, h and j) represent mean ± SEM. Statistical tests in b and h: Two-tailed unpaired multiple
Student’s t test with unequal variance; for bar graph in b, p = 0.023685 (E12.5), p = 0.00002 (E13.5/14.5), p = 0.000777 (E15.5/16.5), p < 0.000001 (P0);
statistical test in e, g and j: Two-tailed unpaired Student’s t test with unequal variance, p = 0.0001 (e), p < 0.0001 (g), p = 0.061246 (h, OTX2),
p < 0.00001 (h, AQP1 and TTR), for (j) p = 0.0029 (Otx2), p = 0.0081 (Aqp1), p = 0.0005 (Ttr), p = 0.0048 (Slc12a2), p = 0.072 (Slc12a4), p = 0.0001
(Slc4a2), p = 0.0268 (Slc4a10). *p < 0.05, **p < 0.01, ***p < 0.001, ns if p value > 0.05. Scale bars: 100 μm (all panels in a and f low mag); 50 μm (c); 10 μm
(all panels in f high mag). Source data are provided as a Source Data ﬁle.

marker E-CADHERIN was examined together with βIII TUBULIN in female β-catenin GOF brains (Supplementary Fig. S7a):
ChPe cells that were Ai9-negative (no Cre activity) never
displayed βIII TUBULIN staining (Supplementary Fig. S7b);
whereas some Ai9-positive (Cre-active) cells were positive for
both E-CADHERIN and βIII TUBULIN labeling (Supplementary
Fig. S7c). In summary, the mosaic expression of the Cre
recombinase in female embryos offered an elegant internal
control in which Cre-driven β-catenin GOF cells resided adjacent
to control (no Cre activity) cells in the same ChPe tissue. These
data demonstrated that ChPe cells that were TTR or
E-CADHERIN positive also expressed βIII TUBULIN in βcatenin GOF brains, and therefore led to the conclusion that cells
that were speciﬁed as ChPe became transformed to a neuronal
fate. The observation that βIII TUBULIN positive cells were
always Ai9 positive further suggests the effect of β-catenin GOF
was likely to be cell-autonomous.
To examine the nature of this apparent neuronal transformation of the Lmx1aCre::β-catenin GOF ChP in a comprehensive
manner, we compared transcriptomic datasets obtained from
microdissected E14.5 hippocampal primordia isolated from the
same telencephalic hemispheres from which the ChP was isolated
for RNAseq (Fig. 2), as illustrated in the cartoon (Fig. 7a;
Supplementary Data 1). Principal Component Analysis (PCA) of
the overall transcriptomes revealed that the Lmx1aCre::β-catenin
GOF ChP is more similar to the control and GOF hippocampus
than it is to the control ChP (Fig. 7b). Consistent with this, the
expression of genes critical for ChP development and function,
such as Aqp1, Htr2c, Kcne2, Otx2, Slc12a2(Nkcc1), are dramatically reduced, and the expression of genes important for neuronal
development such as Emx1, Emx2, Fezf2, Neurod1, Prox1 are
upregulated in the β-catenin GOF ChP (Fig. 7c). Hierarchical
clustering of the top 500 genes expressed in the ChP and the
hippocampus recapitulates this loss of choroid epithelial fate and
gain of neuronal fate in the Lmx1aCre::β-catenin GOF ChP
(Fig. 7d; Supplementary Data 1).
A recent study used single-cell RNAseq for transcriptomic
analysis of the developing mouse ChP and identiﬁed ﬁve distinct
cell types in this tissue, namely epithelial, neuronal, endothelial,
mesenchymal, and immune cells. Dani et al., 202135 identiﬁed 86
ChP epithelial cell-enriched genes in the ChP, and of these, 74 (86
%) were signiﬁcantly downregulated in the Lmx1aCre::β-catenin
GOF ChP, consistent with our interpretation of a loss of ChPe

fate; none were upregulated; 1 gene did not change in expression,
and 11 were not detected. In contrast, of the 274 neuronalenriched genes, 123 (45 %) were upregulated in the Lmx1aCre::βcatenin GOF ChP, consistent with our interpretation of a gain of
neuronal fate; 21 were downregulated and 122 did not change in
expression; 9 were not detected (Fig. 8a–c; Supplementary
Data 1). The genes upregulated in the GOF ChP included several
known regulators of neuron differentiation such as bHLH
members Neurod1, Neurod2, Neurod6, Neurog2, Tcf3, Sox21,
Sox4, Sox1, Zeb1, and Zeb2 (Fig. 8c, Supplementary Fig. S8).
Although the remaining cell types identiﬁed in Dani et al.,
202135 are not known to arise from the hem, it is intriguing that a
substantial fraction of genes enriched in these populations were
also dysregulated in the Lmx1aCre::β-catenin GOF ChP,
suggesting the possibility of noncell autonomous effects of βcatenin GOF in the hem-derived cells. This further suggests
interactions between these cell types that have thus far not been
examined.
Consistent with the apparent neuronal transformation of the
GOF ChP, gene ontology analysis of the Lmx1aCre::β-catenin
GOF transcriptome indicated that genes that were upregulated in
the GOF ChP belonged to the categories like neurogenesis (GO:
0022008), neuron projection development (GO: 0031175), cell
differentiation (GO: 0030154), dentate gyrus development (GO:
0021766, GO: 0021542). We also examined GO categories in
which genes were downregulated in the GOF ChP, and found that
these belonged to classes important for ChP function, such as
cilium organization (GO:0044782) and ion/solute transport
(Supplementary Fig. S8d). We examined the effects of this
transformation on the CSF in Lmx1aCre::β-catenin GOF brains.
It was not possible to extract CSF from Lmx1aCre::β-catenin GOF
brains because the ventricles were collapsed from E13.5 (Fig. 3a).
Therefore, we took the alternative approach of examining a
curated list of 1064 ChP-secretome genes from the published
literature38 and comparing it with the set of genes differentially
expressed in the GOF versus control ChP. 348 of the ChPsecretome genes were dysregulated in the GOF ChP (Fig. 7e). The
majority (211/348) of these genes were downregulated compared
with the control ChP, including several major components of the
CSF such as Igf2, Igfbp2, Ttr (Fig. 7f). Some genes were
upregulated in the GOF ChP, such as Bmp6, Fgf17, Wnt4 and 6,
suggesting a change in the composition of the secreted CSF in
Lmx1aCre::β-catenin GOF brains. Together these results suggest
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Fig. 4 Constitutive activation of β-catenin transforms the ChPe to a neuronal and hippocampal-like molecular identity. (a–c) At E14.5, the control ChPe
is positive for OTX2 but not PAX6 or PROX1. In the control brains 0% OTX2 + cells are also PAX6 + / PROX1 + whereas in Lmx1aCre::β-cat GOF ChPe,
31.9% of the OTX2 + cells are also PAX6 + and 20.3% are PROX1 + . Boxed regions (a) are shown at high magniﬁcation in the adjacent panels (b). (c)
N = 4 (PAX6), N = 5 (PROX1) brains (biologically independent replicates) for each genotype were examined over 4 independent experiments. (d, e) At
E16.5, the Ai9 reporter marks the Lmx1aCre lineage, none (0%) of Ai9+ control ChPe cells are PROX1 + or TBR2 + or, βIII TUBULIN + . In Lmx1aCre::β-cat
GOF brains, 41% of the Ai9+ cells co-label for PROX1, 39.8% for TBR2, and 58% for βIII TUBULIN. (e) N = 5 brains (biologically independent replicates)
for each genotype were examined over 5 independent experiments. (f, g) E18.5 control and Lmx1aCre::β-cat GOF wholemount ChP preparations were coimmunostained for PROX1 and OTX2. The Lmx1aCre::β-cat GOF ChP displays decreased OTX2 labeling and the presence of PROX1 + cells of varying
intensities which never appear in control samples. (h, i) Intensity quantiﬁcation of 20 cells from a single ﬁeld shows a marked decrease in OTX2 intensity in
cells from the Lmx1aCre::β-cat GOF ChPe, and high levels of PROX1 in some of these cells. (f, g) Representative images of sections taken from N = 3 brains
(biologically independent replicates) examined over 2 independent experiments. High mag panels in (f) show representative z plane of the boxed region.
Statistical tests in c and e: two-tailed unpaired multiple Student’s t test with unequal variance. For (c), p = 0.005442 (PAX6), p = 0.0023 (PROX1); (e),
p = 0.000156 (PROX1), p = 0.00264 (TBR2), p = 0.000003 (βIII TUB). *p < 0.05, **p < 0.01, ***p < 0.001, ns if p value > 0.05. Scatter plots (c, e)
represent mean ± SEM. Scale bars: 100 μm (all panels in a and f); 10 μm (all panels in b and g); 50 μm (all panels in d). Further information on replicates
and reproducibility for this ﬁgure is mentioned in the “Statistics and Reproducibility” section of the Methods. Source data are provided as a Source Data ﬁle.
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that the ChP has partially transformed, acquired neuronal
characteristics, and the gene expression data suggest an altered
secretome that would impact CSF composition.
ChPe-like structures arise in hESC organoids upon a combination of BMP and canonical Wnt pathway activation. We
sought to examine whether constitutive activation of canonical
Wnt signaling disrupts ChPe identity in the human, as it does in
the mouse. First, we used established protocols to achieve ChPe
differentiation in hESC-derived organoids39. In this protocol,
hESCs are aggregated and seeded in a 96 well low-adhesion plate,
and over 18 days of incubation, they form spherical structures
which grow in diameter (Fig. 9a, b). At this stage, a morphogen
cocktail containing BMP4 and CHIR, a GSK3 inhibitor, is added.
GSK3 is responsible for phosphorylating β-CATENIN and
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marking it for degradation, so CHIR addition results in a greater
amount of active β-CATENIN40. However, unlike the β-catenin
GOF mouse, CHIR can be added in graded amounts to control
the extent of canonical Wnt pathway activation41. A cocktail
containing a low level of CHIR (3 μM) together with BMP4
(0.5 nM) promotes ChPe-like differentiation39. The spherical
organoids became slightly tapering and developed multiple protrusions within a few days of exposure to the cocktail (Fig. 9b).
Immunohistochemistry revealed ChPe markers TTR, AQP1, and
OTX2 were present along the perimeter of the protrusions, with
cells displaying a cuboidal morphology (Fig. 9c–e). To better
characterize these organoids, we performed RNA-seq after
12 days of exposure to the cocktail. Even though the ChPe-like
differentiation was seen only along the perimeter of the organoid,
the transcriptomic analysis of the sample revealed characteristic
markers of the ChPe such as AQP1, CLIC6, KRT18, and TTR
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Fig. 5 Stabilizing β-CATENIN selectively in the speciﬁed ChPe using FoxJ1Cre causes loss of ChPe fate but not transformation to a neuronal fate. a A
cartoon illustrating the hem (cyan asterisks), choroid plaque (white asterisks), and choroid plexus at E10.5 and E12.5. b Foxj1Cre::Ai9 marks differentiated
choroid plexus at E12.5 but not the choroid plaque at E10.5 or the hem at either stage. Lmx1aCre::Ai9 marks both hem and choroid plexus/plaque starting
from E10.5. Boxed regions (b) are shown at high magniﬁcation in the adjacent panels. Representative images are shown of sections taken from N = 3 brains
(biologically independent replicates) examined over 2 independent experiments. c–e In E16.5 Foxj1Cre::β-cat GOF embryos, LEF1 levels increase (color key:
dark blue indicates grey value =0, white indicates grey value =255), while bonaﬁde ChPe markers AQP1(Boxed regions (c) are shown as high
magniﬁcation insets), TTR, and OTX2 decrease compared with controls, as seen using (c) immunoﬂuorescence and (d) quantiﬁcation of the number cells
positive for each ChPe marker as a fraction of the Ai9-positive cells. A scatter plot shows that in the E16.5 control ChPe, 100% of 500 Ai9+ cells are also
OTX2 + , 98.25% of 942 Ai9+ cells are also AQP1 + , and 98.47% of 1168 Ai9+ cells are also TTR + . In Foxj1Cre::β-cat GOF ChP, 91.6% of 731 Ai9+ cells
are also OTX2 + , 33.3% of 781 Ai9+ cells are also AQP1 + , and 47% of 1097 Ai9+ cells are also TTR + . (c, d) N = 5 (OTX2) and N = 6 (AQP1 and TTR)
brains (biologically independent replicates) for each genotype examined over 3 independent experiments. Bars represent mean ± SEM; p = 0.088919
(OTX2), p = 0.000129 (AQP1), p = 0.000783 (TTR). (e) A violin plot reveals that the nuclear intensity of OTX2 labeling decreases signiﬁcantly in
Foxj1Cre::β-cat GOF ChPe cells compared with controls. n = 536 nuclei from control and 590 nuclei from Foxj1Cre::β-cat GOF ChPe; N = 5 brains
(biologically independent replicates) examined over 3 independent experiments; solid black line represents median and dotted lines represents quartiles;
statistical test: two-tailed unpaired multiple Student’s t test with unequal variance; p < 0.0001; *p < 0.05; **p < 0.01; ***p < 0.001; ns if p value > 0.05. f In
control and Foxj1Cre::β-cat GOF brains, PROX1 immunostaining is seen in the dentate gyrus, PAX6 and TBR2 appear in the telencephalic ventricular and
sub-ventricular zones, respectively, and βIII-TUBULIN is present in postmitotic neurons in the dorsal telencephalon. None of these markers appear in the
ChPe of either genotype (solid lines), except for a few βIII-TUBULIN positive neurons that normally populate the ChPe. Boxed regions (f) are shown at high
magniﬁcation in the adjacent panels. Representative images are shown of sections taken from N = 3 brains (biologically independent replicates) examined
over 2 independent experiments. Scale bars: 100 μm (all panels in b, c, and f); 10 μm (all panel in c inset). Source data are provided as a Source Data ﬁle.

(Fig. 9f). Interestingly, genes associated with the blood-CSF barrier (BCSFB), such as CDH1, CLDN3, JAM2, TJP1, and TJP2 and
were also upregulated, as were several transporters and ion
channels encoded by the SLC gene family and genes associated
with ciliogenesis, consistent with the ciliated epithelium nature of
the ChPe (Supplementary Fig. S9). In summary, consistent with
Sakaguchi et al. (2015)39, ChPe-like structures develop in organoids upon exposure to a cocktail of BMP4 and low levels of
CHIR.
Loss of ChPe-like identity upon increased activation of canonical Wnt signaling in hESC-derived organoids. We examined
the effect of increased activation of canonical Wnt signaling in the
hESC-derived organoids. We tested a range of concentrations of
CHIR (3–12 μM) in the cocktail added to the organoids after
18 days in vitro, keeping the BMP4 concentration constant. The
organoids were examined for the presence of Ttr/ TTR, Aqp1/
AQP1, and Otx2/ OTX2 by immunohistochemistry, qPCR analysis, and RNA-Seq (Fig. 10). As early as 7 days post CHIR
treatment (25 days in vitro), 3 μM-treated organoids displayed
multiple domains of TTR decorating the perimeter, but 12 μMtreated organoids displayed no detectable TTR (Fig. 10c; Supplementary Fig. 10c). We tested the dose-response to CHIR
treatment by immunostaining for TTR, AQP1, and OTX2 in
organoids using the different CHIR regimens. Whereas all three
proteins appeared along the perimeter of 3 μM CHIR-treated
organoids, they were undetectable in organoids treated with
higher CHIR concentrations (Fig. 10d; Supplementary Fig. S10d).
qPCR analysis conﬁrmed this ﬁnding: upon treatment with 3 μM
CHIR, TTR, AQP1, and OTX2 displayed a signiﬁcant increase in
fold expression over the baseline (untreated 18-day organoids).
However, treatment with 12 μM CHIR appeared to suppress the
expression of these genes to levels below the baseline (Fig. 10e). In
contrast, LEF1 expression correctly reﬂected the increased activation of canonical Wnt signaling by displaying a graded increase
in fold expression above baseline upon 3 μM and 12 μM CHIR
treatment (Fig. 10f).
To obtain a comprehensive picture of the effect of increased
canonical Wnt pathway activation on hESC-derived organoids,
we performed RNA-seq of 3 μM and 12 μM CHIR-treated
samples. Several major ChPe markers detected in the 3 μMtreated condition are suppressed upon 12 μM CHIR treatment
(Fig. 10g). These include markers of differentiated ChPe such as
10

AQP1, TTR, OTX2; genes that encode proteins that participate in
forming tight junctions that are typical of the ChPe, such as
CLDN1, 2, 5, and TJP1,3; and those that encode transporters or
ion channels such as CLIC6, SLC4A10, SLC12A7, and SLC12A8.
The transcriptome of the 12 μM CHIR-treated organoids did not
display upregulation of neuronal markers. One possible reason
for this could be that any such transformation would have been
limited to the periphery of the organoid, and the corresponding
transcriptomic changes may have become masked due to the
larger contribution of the rest of the organoid. We, therefore,
examined 3, 6, 9, and 12 μM CHIR-treated organoid samples by
immunohistochemistry using a neuronal marker that is enriched
in the hippocampus, ZBTB2042 and a choroid epithelium marker
OTX2. We discovered that with increasing CHIR treatment, the
organoid samples reveal a signiﬁcant reduction in OTX2 + cells
and a corresponding increase in ZBTB20 + cells (Supplementary
Fig. S11). Additional analysis would be needed to test whether
this indeed represents a transformation to a neuronal identity.
In summary, stabilizing β-CATENIN in hESC-derived organoids leads to the loss of ChPe identity, consistent with the
ﬁndings in the β-Catenin GOF mouse.
Discussion
The ChP actively processes canonical Wnt signaling from the
earliest stages of its development. Expression of the reporter
BAT-Gal and target gene Axin2 was reported in the choroid
plaque at E10.5 and the ChPe at E11.534. Similarly, the expression
of both Lef1, as well as a LEF1-βGal allele, were reported in the
E12.5 mouse ChP43. Furthermore, the expression of Lef1,
Axin243,44, Tcf7 (named Tcf1 in45), several Frizzled receptors
(Fzd1, Fzd2, Fzd3, and Fzd7)46 as well as the phosphorylated
LRP6 co-receptor is present in the developing ChPe47. Consistent
with these reports, we found that loss of β-CATENIN, which
mediates canonical Wnt signaling, disrupts the normal development of the telencephalic ChP.
It appears, however, that a regulated level of canonical Wnt
signaling is critical for ChPe differentiation. Constitutive activation of canonical Wnt signaling results in a profoundly defective
ChPe both in the mouse embryo and in hESC-derived ChP
organoids. Since this pathway regulates multiple aspects of cellular, tissue, and organ development, several other systems that
require canonical Wnt signaling for normal development also
display an array of defects upon its constitutive activation. During

NATURE COMMUNICATIONS | (2022)13:633 | https://doi.org/10.1038/s41467-021-27602-z | www.nature.com/naturecommunications

NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-27602-z

human hair follicle morphogenesis, loss or constitutive activation
of β-CATENIN leads to tumor formation or defective differentiation, respectively48,49. There are some examples in which
constitutive activation of β-CATENIN appears to transform cell
identity. The mouse epiblast prematurely displays epithelial to
mesenchymal transition50; endothelial cells of the midbrain
transform to a “barrier cell” identity51, and airway epithelial cells
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take on a neuroendocrine-like fate52. Our study reports an
apparent transformation of speciﬁed ChPe cells to a neuronal fate
upon constitutive activation of β-CATENIN in their progenitor
domain, the hem, which parallels the ﬁndings in the other systems mentioned above.
An unexpected feature is that the transcriptome of the β-catenin
GOF ChP has some components that ﬁt with a CR cell-like proﬁle,
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Fig. 6 β-Catenin GOF causes upregulation of β-III TUBULIN in TTR + ChPe cells. (a–c) At E12.5, both control and Lmx1aCre::β-Catenin GOF ChP display a
ribbon-like morphology and do not express hem markers Wnt2b and BLBP (a) but express Ttr mRNA and TTR protein (b). (c) Co-immunostaining for β-III
TUBULIN and TTR identiﬁes cells that display both markers in the β-Catenin GOF but not in the control ChPe. (a–c) Representative images are shown of
sections taken from N = 3 brains (biologically independent replicates) examined over 2 independent experiments. Boxed regions (c) are shown at high
magniﬁcation in the adjacent panels. (d–g) At E13.5, male Lmx1aCre::Ai9 control and Lmx1aCre::Ai9::β-Catenin GOF brains display Cre-driven Ai9-positive
cells throughout the ChPe (d, f), In contrast, female control and β-Catenin GOF brains show mosaic Ai9 due to random X-inactivation (e, g). β-III TUBULIN
is undetectable in the female control ChPe, but appears selectively in the Ai9+ patches in the female β-Catenin GOF ChPe (e, g). (h–k). In females, neither
control Lmx1aCre::Ai9 ChPe cells (cells #1–4; h, i) nor non-Ai9 cells internal control cells in Lmx1aCre::Ai9::β-Catenin GOF ChPe (cells #5–8; j, k) display
co-localization of β-III TUBULIN and TTR. These markers are both detected in Ai9-positive Lmx1aCre::Ai9::β-Catenin GOF ChPe cells (#9–12; l, m). (d–l),
Representative images are shown of sections taken from N = 3 brains (biologically independent replicates) examined over 2 independent experiments. (i,
k, m) Fluorescence intensity quantiﬁcations of cells #1–12 from (h, j, l). Boxed regions (e, g) are shown at high magniﬁcation in the panels (h, j, l) below.
Scale bars: 10 μm (all high mag panels in c and all panels in h–l); 50 μm (all panels in a–e). Further information on replicates and reproducibility for this
ﬁgure is mentioned in the “Statistics and Reproducibility” section of the Methods. Source data are provided as a Source Data ﬁle.

such as Ebf2, Jph3, Reelin, Slit153, and others that ﬁt with a medial
cortical/hippocampal-like proﬁle (Lef1, Prox1, Wif1), in addition
to an array of cortical neuroepithelial or postmitotic neuronal
markers (Supplementary Table 1). While it is not possible to
delineate whether there is a heterogenous population of CR-like,
hippocampal-like, and cortical neuron/neuronal progenitor-like
cells in the β-catenin GOF ChP using bulk RNAseq, it appears that
the overall picture is one of the mixed transcriptomic signatures,
at least at a population level. Fate choice between ChPe and CR
cells is regulated by transcription repressors of the bHLH family
members, HES1, 2, and 3, that promote epithelial identity by
suppressing neurogenic genes and inducing BMP signaling54.
Upon loss of all three Hes genes, the hem upregulates the proneuronal factor NEUROG2 and produces CR cells instead of ChPe
cells55. Our results suggest that the canonical Wnt pathway may
intersect with this regulatory mechanism. β-CATENIN is also
involved in cell adhesion, which is an important factor in the
epithelial organization. In addition, the hem also expresses
Wnt5a12 and WNT5a acts via the non-canonical Wnt-PCP
pathway to regulate ChPe cytoarchitecture, apicobasal polarity,
and overall size and complexity of the ChP18. BMPs are known to
be critical for the speciﬁcation of the ChP16. Thus, multiple signaling molecules of the WNT and BMP families present in the
hem are each critical for ChP development. A comprehensive
analysis of interactions between these factors and the pathways
they regulate may offer insight on the regulation of multipotency
of progenitors in the hem, and the temporal trajectory of ChPe
differentiation.
Activation of the canonical Wnt pathway is often
tumorigenic21. Human cases of ChP carcinoma are associated
with mutations in exon 3 of the ß-CATENIN gene that lead to its
constitutive activation20,21. Mouse models of ChP papilloma that
are generated by constitutive activation of NOTCH signaling show
concomitant upregulation of the canonical Wnt pathway22. It is
not clear what mechanisms control whether canonical Wnt activation causes cell fate transformations or tumorigenic changes, but
it is likely that crosstalk with other major signaling pathways is
involved. The β-catenin GOF mouse ChP offers a useful and
accessible model in which this question can be examined.
Key features of β-catenin GOF in the ChP include dysregulation of factors that are essential for the ChP to produce the CSF.
These include several anion cation exchangers, ion channels, and
solute transporters, each of which acts as a regulator of CSF
composition: a sodium-potassium ATPase, Atp1a155; an epithelial sodium channel, Scnn1a56; an inward rectifying potassium
channel, Kcnj1357; a voltage-gated potassium channel, Kcna158;
and a sodium-potassium-chloride cotransporter, Nkcc1, that
modulates water transport underlying CSF production59 and is
also associated with Blood CSF barrier disruption60. Furthermore,
the expression of several genes encoding for glucose, chloride, and
12

amino acid transporters, is also downregulated in the β-catenin
GOF ChP. Together, the data suggest that canonical Wnt signaling may be an important factor in enabling the ChPe to
produce normal CSF. Mutations in exon 3 of ß-CATENIN in
humans result in stabilization of β-CATENIN61, similar to that
seen in the β-catenin GOF mouse model26. Human studies have
focused on the association of these mutations with
carcinomas21,61, but no associated effects on the CSF have been
explored. Our study identiﬁes a potentially important developmental outcome of the β-catenin GOF perturbation in terms of its
possible effect on the composition of the CSF. The formation of
ChPe in hESC-derived organoids requires low activation of the
canonical Wnt pathway together with BMP signaling. Loss of
ChPe fate in these organoids upon high activation of the canonical Wnt pathway indicates conservation of the role of this
pathway in the development of the ChPe. hESC-derived organoids are not only an excellent system to study conserved
developmental mechanisms but also offer the opportunity to test
for subtle effects of altered ChP/CSF status on neuronal cells.
Depending on the protocol used, the organoids develop into
ﬂuid-ﬁlled cysts that contain several human CSF proteins62.
These organoids are permeable to small molecules and are
excellent model systems to test modalities of drug delivery to the
CNS62. Thus, hESC-derived ChP organoids offer a suitable system to model both diseases, as well as modalities for treatment.
In conclusion, we demonstrate that the developing choroid
plexus expresses components of the canonical Wnt signaling
pathway in embryonic mouse and human brains. Both loss and
gain of function of β-CATENIN disrupt ChPe development,
indicating that this pathway is likely to be under a ﬁnely tuned
regulation in vivo. These ﬁndings motivate future studies on how
this regulation is achieved and may provide a mechanistic basis
for subtle deﬁcits in ChP/CSF function connected to the disruptions of the canonical Wnt pathway function in this system.
Methods
Tissue collection
Mice. All animal protocols were approved by the Institutional Animal Ethics
Committee of the Tata Institute of Fundamental Research, Mumbai, India. The
mouse lines used in this study were kind gifts from Kathy Millen (Center for
Integrative Brain Research, Seattle Children’s Research Institute; Lmx1aCre line25),
Raj Awatramani (Department of Neurology and Center for Genetic Medicine,
Northwestern University Feinberg Medical School Chicago, Illinois; β-catenin LOF
mice31, Michael J. Holtzman (University of Washington, St. Louis), USA; Foxj1Cre
line36,37. The Ai9 reporter mouse line was obtained from JAX labs Stock No.
007909. All animals were kept in an ambient temperature and humidity, with a
12 hr light-dark cycle and food available ad libitum. Noon of the day of the vaginal
plug was designated as embryonic day 0.5 (E0.5). Animals of both sexes were used
for generating the control and Foxj1Cre::β-catenin GOF brain samples. For
Lmx1aCre animals, since the transgene is on the X-Chromosome, females showed
mosaic expression of the Cre recombinase due to random X inactivation. Crepositive male embryos/pups were used for analysis except from Fig. 6 and Supplementary Fig. S7 where female embryos were analyzed. Controls were littermates
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Fig. 7 Constitutive activation of β-CATENIN leads to a dysregulation of the ChP transcriptome. (a) A cartoon depicting the microdissection E14.5 ChP
and hippocampus for RNAseq analysis. (b) Principal Component Analysis (PCA) of the RNAseq datasets. (c, d) Choroid plexus-enriched genes are
downregulated, and hippocampus/neuron-enriched genes are upregulated in the Lmx1aCre::β-catenin GOF ChP. In (c) log2 fold changes of 31
representative choroid plexus-enriched genes and 20 neuron-enriched genes are plotted (Padj < 0.05), (d) heatmap and hierarchical clustering show read
counts of 500 choroid enriched and 500 hippocampus enriched genes from the RNA-seq dataset (Supplementary data 1). (e, f) Venn diagram showing the
overlap between genes corresponding to the ChP secretome (from Lun et al. 2015.) and differentially expressed genes in the Lmx1aCre::β-catenin GOF
versus control ChP and heat map of selected genes plotted as read counts (e) shows the dysregulated genes belong to various known pathways of cell-cell
signaling (f). Color bars in (d, f): blue (low expression), red (high expression). For RNAseq experiments (c, d, and f) N = 2 biologically independent
replicates. Further information on replicates and reproducibility for this ﬁgure is mentioned in the “Statistics and Reproducibility” section of the Methods
and Supplementary data 1. Source data are provided as a Source Data ﬁle.
wherever possible. Control embryos/pups carrying the Ai9 reporter to mark the
Lmx1a or Foxj1 lineage carried the respective Cre transgenes. Breeding colonies
were maintained with the female breeders carrying the Lmx1aCre and Foxj1Cre
transgenes since this germline recombination occurs in the testes of these lines.
Primers used for genotyping were: Cre F: 5′ATTTGCCTGCATTACCGGT
C3′, Cre R: 5′ATCAACGTTTTCTTTTCGG3′, Cre-positive DNA shows a band at
350 bp. For detecting β-catenin LOF (Exon2–6 ﬂoxed) following primers were
used: RM41 5′AAGGTAGAG TGATGAAAGTTGTT3′; RM42 5′CACCATGTC

CTCTGTCTATTC3′; RM43 5′TACACTATTGAATCACAGGGACTT3′31. The
PCR shows 221 bp as Wild type band while 324 bp as band corresponding to ﬂoxed
allele. For genotyping β-catenin GOF (Exon 3 ﬂoxed) FP 5′ GCTGCGTGGACAATGGCTAC3′ and RP 5′GCTTTTCTGTCCGGCTCCAT3′26 was used which
detects conditional allele at 550 bp and wild type band at 350 bp in PCR.
Human. The Institutional Ethical Review Board of the School of Medicine, University of Zagreb, and University Hospital Center Zagreb have approved the
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Fig. 8 Cell-type classiﬁcation of genes dysregulated upon constitutive activation of β-CATENIN. (a) comparison of RNA-seq data from E14.5
Lmx1aCre::β-catenin GOF ChP with scRNA-seq data from E16.5 ChP (Dani et al., 2021). Genes that were differentially expressed (DE) between the
Lmx1aCre::β-catenin GOF ChP and control ChP (Supplementary data 1) were compared with the genes enriched in Epithelial/Neuronal/Endothelial/
Mesenchymal/Glial/Immune cell groups identiﬁed in Dani et al., 2021. For each cell group, the DE list contained genes that were either upregulated (blue),
downregulated (orange), or unchanged/undetected (grey). (b, c) Log2 fold change (Padj < 0.05) selected choroid plexus epithelial genes (74
downregulated) and neuronal-enriched genes (122 upregulated and 21 downregulated) that were dysregulated in the Lmx1aCre::β-catenin GOF ChP upon
comparison with Dani et al., 2021. Bar graphs are color coded as Upregulated (blue), downregulated (orange). For RNAseq experiments (a, b, and c) N = 2
biologically independent replicates. Further information on replicates and reproducibility for this ﬁgure is mentioned in the “Statistics and Reproducibility”
section of the Methods and Supplementary data 1. Source data are provided as a Source Data ﬁle.

procedure for collecting postmortem brain samples and their use for research
purposes in the study under protocol numbers: UHC Zagreb EP02/21AG; Class
8.1–17/170-2 and UZSM: 641-01/19-02/01, No. 380-59-10106-19-111/201). Fetal
brain specimens were obtained in autopsies following elective termination or
spontaneous abortions with the written informed consent of the mother, according
to the Helsinki declaration (compensation to mothers was not involved). The fetal
age was estimated based on crown-rump length (CRL, in mm), pregnancy records,
and histological ﬁndings and expressed as GW. In addition, the correlation of
maturational parameters (CRL, body mass, pregnancy records, and sonographic
examination) revealed no evidence of growth retardation or malformations. Finally,
specimens in which subsequent postmortem analysis revealed macroscopically or
14

microscopically identiﬁed pathological changes, or postmortem autolytic changes,
were excluded.

Choroid plexus dissection. All dissections were performed in ice-cold PBS. For
wholemount immunostained ChP preparations, telencephalic hemispheres were
isolated using #5 forceps under a stereo zoom microscope (Nikon SMZ445). The
rostral part of the ChP was gently extracted from the telencephalic ventricle using
blunt forceps. The ChP was dissected using microdissection scissors while stabilizing the hemisphere using blunt forceps. For RNA Seq/ qPCR experiments, we
used a line carrying the Ai9 reporter to avoid contamination from adjacent tissues.
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Fig. 9 Differentiation of hESC organoid cultures using a ChPe differentiation-promoting protocol. a Schematic presentation describing the organoid
culture protocol. (b) Bright-ﬁeld images of organoids at different stages of development. Representative images from N = 48 organoids (biologically
independent replicates) examined over 3 separate experiments. (c, d) Immunostaining reveals the presence of choroid markers OTX2 and TTR in the
perimeter of the protrusions of a day 40 organoid. Boxed region (c, d) is shown at high magniﬁcation in the adjacent panels. (e) AQP1 immunostaining in
Day 40 organoids is similar to that seen in the E14.5 mouse ChP. (c–e) Representative images of sections taken from N = 12 organoids (biologically
independent replicates) examined in 2 separate experiments. (f) Heatmap and hierarchical clustering generated from normalized reads obtained by MARSSeq show upregulation of ChP-enriched genes by day 30 of the organoid culture (N = 3 biologically independent replicates). Scale bars: 200 μm (all panels
in b); 100 μm (c); 10 μm (all panels in d and e). Source data are provided as a Source Data ﬁle.

We examined the brains for Ai9 ﬂuorescence before and after microdissection to
ascertain that the Ai9-positive hem remained intact (Fig. 2d). Furthermore, we
isolated only the region of the ChP that was easily accessible and protruded into the
telencephalic ventricle.
Immunohistochemistry
Mouse sections and organoids. Mouse brain sections/organoid sections were
mounted on plus slides (Catalogue number: EMS 71869-11) and dried for 2–3 h.
Slides were transferred to a slide mailer (Catalogue number: EMS 71549-08)
containing PBS + 0.01% TritonX-100 for 10 min followed by a wash with PBS +
0.03% TritonX-100 for 5 min. For antigen retrieval, sections were boiled in a
10 mM sodium citrate buffer (pH = 6) at 90°C for 10 min using a water bath. Slides
were cooled to room temperature and washed with PBS + 0.01% TritonX-100 for
10 min. Blocking (5% horse serum/Lamb serum in PBS + 0.1% TritonX-100) for
1 h followed by overnight primary antibody incubation at 4 °C. Secondary antibody
incubation was performed at room temperature for 2 h followed by three washes
with 1x PBS. Slides were mounted using vectashield mounting media (Vector
laboratories H-1000-10) and imaged in an Olympus FluoView 1200 confocal
microscope. The primary antibodies used were: LEF1 (rabbit, 1:200 CST catalogue
# C12A5), β-CATENIN (mouse 1:200, BDbiosciences catalogue # 610153), βCATENIN (rabbit 1:50, CST catalogue # 8814), RFP (rabbit, 1:200 Abcam catalogue # ab62341), FZD1 (rabbit, 1:100 catalogue # LS-A4150), AXIN2 (rabbit, 1:200
Abcam catalogue # ab185821), TTR (rabbit 1:100, DAKO catalogue # A0002),

AQP1 (mouse, 1:200 SCBT catalogue # sc25287), OTX2(mouse, 1:200 SCBT catalogue # sc-514195), OTX2(1:500,invitrogen,PA5-39887), AQP1 (rabbit,
1:200,invitrogen catalogue # MA5-32593), E-CADHERIN (mouse, 1:200,
SCBTcatalogue# sc21791), E-CADHERIN (mouse,1:100 BD Bio transductions,
catalogue # 610182 0Cleaved CASPASE 3 (rabbit, 1:200 CST catalogue # 9664),
Phospho HISTONE (rabbit, 1:200 CST catalogue # H0412), TBR2 (rabbit, 1:200
Abcam catalogue # ab23345), PAX6 (rabbit, 1:500 Abcam catalogue # ab195045),
PROX1 (rabbit, 1:500 Millipore catalogue # ab5475), β-III TUBULIN (mouse,
1:100 Promega catalogue # G7128), BLBP (rabbit, 1:200 sigma catalogue # ABN14),
ACTIN (mouse, 1:500 sigma catalogue # A2228), LAMININ (rabbit, 1:200 sigma
catalogue # L9393). Secondary antibodies used were following: Goat Anti Rabbit
Alexa ﬂuor 488 (1:200, Invitrogen catalogue # A11034), Goat Antimouse Alexa
ﬂuor 594 (1:200, Invitrogen catalogue # R37121), Goat Anti Rabbit Alexa ﬂuor 568
(1:200, Invitrogen catalogue # A11011), Donkey Anti goat Alexa ﬂuor 568 (1:200,
Invitrogen catalogue # A32814), Donkey Antirabbit Alexa ﬂuor 647 (1:200, Invitrogen catalogue # A31573).
Human. The entire brains were ﬁxed by immersion in 4% paraformaldehyde in
0.1 M phosphate buffer saline (pH = 7.4). Subsequently, tissue blocks were
embedded in parafﬁn wax. Serial sections were cut (5 μm) and stained. The cresyl
violet staining was used to delineate cytoarchitectonic boundaries, while adjacent
sections were labeled using immunoﬂuorescence with various antibodies. The
following primary antibodies were used: (1) rabbit polyclonal anti-Axin 2,
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Fig. 10 High activation of the canonical Wnt pathway in hESC-derived organoids causes suppression of ChPe markers. a A schematic presentation of
the protocol for the treatment of organoids with the canonical Wnt agonist CHIR. b, c The ChP marker TTR is present in the periphery of a day 25 organoid
exposed to 3 μM, but not when exposed to 12 μM CHIR, from day 18. c N = 4 organoids (3 μM CHIR) and 5 organoids (12 μM CHIR treated); were used for
immunohistochemistry analysis. d High magniﬁcation images (boxed region shown in b) of serial sections of a day 40 organoid exposed to 3 μM reveal the
presence of TTR, AQP1, and OTX2 in the periphery. This labeling is reduced or undetectable upon exposure to higher concentrations of CHIR (6/9/12 μM).
d N = 14 organoids (3 μM CHIR), 9 organoids (6 μM CHIR), 5 organoids (9 μM CHIR treated), and 14 organoids (12 μM CHIR treated) from 2 independent
experiments were used for analysis (each organoid was considered as an independent biological replicate). Additional examples are provided in
Supplementary Fig. S10. e q-PCR analysis shows that the expression of the ChP markers TTR, AQP1, and OTX2 is upregulated in organoids at day 30
organoids exposed to 3 μM CHIR from day 18. This increased expression is lost upon treatment with 12 μM CHIR for the same period. (f) LEF1 expression
displays a stepwise increase upon 3 μM and 12 μM CHIR treatment, consistent with increased activation of the canonical Wnt pathway. Bar graphs (e, f)
represents mean ± SEM. Group means were compared using one-way ANOVA followed by post hoc Tukey’s multiple comparison test, p < 0.0001(e, f), *p
value<0.05, **p value<0.01, ***p value<0.001; (e, f) N = 8 biologically independent replicates examined over 3 independent experiments. (g) Heatmap and
hierarchical clustering comparing normalized RNA-seq reads for 3 μM and 12 μM CHIR-treated organoids. Several ChP-enriched genes are downregulated
with increased activation (12 μM CHIR) of canonical Wnt signaling (N = 3 biologically independent replicates). Scale bars: 100 μm (all panels in c and d).
Source data are provided as a Source Data ﬁle.
(ab185821, Abcam); (2) the rabbit polyclonal Frizzled 1 antibody, FZD1 (LSA4150, LSBio); (3) the monoclonal rabbit LEF1 antibody (C12A5, CST); (4) the
mouse monoclonal aquaporin1 antibody, AQP1 (sc-25287, SCBT); (5) Rabbit
nonphospho (Active) βCatenin (D13A1, Cell Signaling, Leiden, Netherlands); (6)
monoclonal mouse OTX2 antibody (MA5-15854, Invitrogen); (7) the mouse
16

monoclonal Beta-Catenin, (M3539, Dako Agilent). The dewaxing of sections was
performed in xylol for 5 min and a series of alcohol solutions (100%, 96%, 70%) for
2 min. Slides were then washed in PBS with 0.03% triton (10 min). The antigen
retrieval was performed in citrate buffer pH6.0 and microwave (800 W) for 10 min.
The slides were cooled at room temperature and immersed in a blocking solution
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(PBS containing 3% bovine serum albumin, BSA, and 0.01 % Triton X-100, all
from Sigma, St. Louis, MO) for 30 min. to prevent nonspeciﬁc background staining.
Sections were then incubated with primary antibodies for 48 h at 4 ˚C (AXIN2
1:100, FZD1 1:100, LEF1 1:100, AQP1 1:100, OTX2 1:50, β-Catenin cell signaling
1:400, β-Catenin Dako 1:200), washed and subsequently incubated with secondary
antimouse or antirabbit antibodies diluted in PBS (at 1:1000) for 2 h at the room
temperature. For visualization of the speciﬁc immune reactivity following secondary antibodies were used according to the laboratory protocol63: the donkey
antimouse IgG Alexa ﬂuor-plus 488, donkey antirabbit IgG Alexa ﬂuor-plus 647,
donkey antirabbit IgG 488, donkey antimouse IgG Alexa ﬂuor 546 were used.
Sections were covered with a mounting medium containing DAPI. Negative controls were included in all experiments by replacing the primary antibody with a
blocking solution. No immunolabeling was detected in the control sections.

visual bias. Similarly, while scoring markers, the Ai9 or DAPI channel was hidden
using the “channel tool”. Similarly, ROI was drawn around the cytoplasm using the
β-III TUB channel in Fig. 6 and intensity was quantiﬁed from the Alexa 488 (TTR)
and Alexa 647 (β-III TUBULIN) channels.
For Supplementary Fig. S11c and d, a region of width 100 µm was drawn using
a “freehand line tool,” and the marker+ cells were scored using the “cell counter”
plugin in Fiji.
Image stitching was performed for Fig. 4d and f (low mags) using the “pairwise
stitching” plugin in Fiji. The “subpixel accuracy” parameter was selected for all the
stitching operations.
Nonlinear operations e.g. gamma adjustment were not performed in any of the
ﬁgures. Brightness and contrast adjustments were performed identically for control
and mutant conditions.

In situ hybridization. Plasmids used to generate probes for in situ hybridization
were kind gifts from Elizabeth Grove (Axin2, Wnt3a, Ttr), Cliff Ragsdale (Fzd1,
Fzd2a) Kathleen Millen (Lmx1a). Fixed mouse brains were sectioned using a
freezing microtome (Leica SM2000R Sliding Microtome) at a thickness of 20 μM.
Sections were mounted on super frost plus slides (Catalogue #: EMS 71869-11),
postﬁxed with 4% (w/v) paraformaldehyde for 15 min, washed three times with
PBS. The sections were then treated with proteinase K dissolved in Tris-EDTA
buffer (1 μg/ml). Post ﬁxation was performed in 4% PFA for 15 min, and the
sections were washed three times in PBS. Hybridization was performed for 16 h at
70 °C in a buffer containing 50% (v/v) formamide, 2X SSC, and 1% (w/v) SDS.
Digoxigenin (DIG)-labeled cRNA probes were used for hybridization and were
prepared from the respective plasmids using the in-vitro transcription. After
hybridization, three stringent washes (for 45 min each) were performed in solution
X (50% formamide, 2X SSC, and 1% SDS) followed by a wash with 2XSSC and then
0.2XSSC. Blocking was performed for 1 hr with 10% horse serum in TBST (Trisbuffered saline pH 7.5 with 0.1% Tween-20). Sections were incubated in alkaline
phosphatase-conjugated anti-DIG (Digoxygenin) antibody Fab fragments (1:5000;
Roche, catalog #12486523) at 1:5000 in the blocking buffer and incubated at 4 °C
overnight. The color reaction was performed using NBT/BCIP substrate (Roche,
4-nitroblue tetrazolium chloride, catalog #70210625; 5-Bromo- 4-chloro-3-indolyl
phosphate, catalog #70251721). Counterstaining was performed using Fast Red
(Sigma-Aldrich, catalog # N3020). Slides were dried and coverslipped using DPX
mounting reagent (SDFCL, catalog #46029). Probes used for in-situ hybridization
were generated using an in-vitro transcription reaction. Linearized templates for
this process were generated by restriction digestion of plasmids (described in64).
Plasmids used to generate probes for in situ hybridization were kind gifts from
Elizabeth Grove (Axin2, Wnt3a, Wnt2b, Ttr), Cliff Ragsdale (Fzd1, Fzd2a) Kathleen Millen (Lmx1a).

Generation of hESC-derived organoids. The human ES cell line WIBR3, obtained
from the Whitehead Institute for Biomedical Research, (https://hpscreg.eu/cellline/WIBRe001-A), was used in compliance with all applicable statutes and regulations and compliance with applicable guidelines (including the NAS Guidelines
or guidelines of the International Society for Stem Cell Research as relevant to the
conduct of human embryonic stem cell research [“ISSCR Guidelines”]. The line
was cultured on an irradiated MEF (mouse embryonic ﬁbroblast) feeder layer. To
maintain the pluripotent state, a customized human Naïve media with 40 μM Rock
Inhibitor Y-27632 was used as described in Karzbrun et al., 201866. Differentiation
of hES aggregates into Choroid plexus-like organoids was done using a protocol
described in Sakaguchi et al. 201539. Brieﬂy, hESC colonies were grown in a
Matrigel-coated plate till conﬂuence. The cells were dissociated with trypsin and
rapidly reaggregated in an ultra-low attachment 96 well V bottom plate (9000 cells
per well) containing a media termed SA1 media. This media contains DMEM
(Invitrogen cat # 11965092) supplemented with 20% (vol/vol) KSR (Invitrogen cat
# 10828028), 0.1 mM non-essential amino acids (Invitrogen cat # 11140050), 1 mM
pyruvate (Invitrogen cat # 11360070), 0.1 mM 2-mercaptoethanol (Invitrogen cat #
21985023), 100U/ml penicillin and 100 mg/ml streptomycin. 0.3 mM IWR1e
(tankyrase inhibitor, MedChemExpress cat# HY-12238) and 5 mM SB431542
(TGFβ inhibitor; MedChemExpress HY-10431) were added to culture from day 0
to day 18 (day of aggregation was deﬁned as day 0). The culture media used after
day 18 till day 40 was termed as SA2, which contains DMEM/F-12 (Invitrogen cat
# 21331020), GlutaMAX(TM) (Gibco) supplemented with 1% N-2 supplement
(Invitrogen cat # 17502048), 1% Chemically Deﬁned Lipid Concentrate (Invitrogen
cat # 11905031), fetal bovine serum (FBS; 10% vol/vol), 3 μM CHIR 99021 (GSK3
inhibitor; MedChemExpress cat # HY-10182) and 0.5 nM BMP4 (R&D cat # 314BP-050) under normoxia condition. The medium was changed once every 2 days.
From day 5 onwards, the plates were kept on an orbital shaker placed inside the
incubator. On day 18 the organoids were transferred from 96 well plates to a 10 cm
ultra-low attachment plate (6 organoids per plate) and kept on an orbital shaker
inside the incubator. For sample collection, the organoids were rinsed with 1x PBS
2 times, then either ﬂash-frozen for RNA-seq experiments or transferred to a small
dish containing 4% PFA solution for immunohistochemistry.

Image acquisition and analysis. Bright-ﬁeld images were acquired using Zeiss
Axioskop-2 plus microscope equipped with a Nikon DS-ﬁ2 camera and associated
software (NIS Elements V4.0). Mouse sections were imaged in Olympus FluoView
1200 confocal microscope and the human brain sections were imaged in Olympus
FluoView 3000 confocal microscope. All the organoid sections were imaged using
the Andor Dragonﬂy spinning disk confocal microscope system. All the image
analysis was done on Fiji-ImageJ, Imaris (Version 7.2.3), and/or Adobe
Photoshop CS6.
For intensity quantiﬁcation (Fig. 1e), a line was drawn across the cell using the
“line tool” option in Fiji (arrowheads mark the origin), and “grey values” were
measured across the line.
For area measurements (Fig. 3b) ROIs were drawn using the “freehand selection
tool” around the Ttr + domains, and area was calculated. In the Lmx1a Cre:: β
Catenin GOF brains where the Ttr + domains appear to be sparse, multiple ROIs
were drawn separately and added in the ROI manager. The area for each
Ttr + domain was calculated and summed to obtain the total area.
For nuclear intensity quantiﬁcation of β-Catenin GOF (Fig. 1j; Fig. 2c and i;
Supplementary Fig. S2b and d; Fig. 3d; Fig. 5e) control and Lmx1a Cre::β Catenin
GOF/LOF coronal sections were mounted on the same slide and processed for
immunostaining. Images were acquired under similar PMT settings with a pixel
distribution of 1024 ×1024 in “sequential scan mode”. The PMT setting was
optimized such that saturation can be avoided. The z stack images are projected as
“SUM slices”and bit depth was set as “8 bit”. From a composite image containing
DAPI and markers, ROIs were drawn around the DAPI + nuclei using the
“freehand selection tool” in Fiji. When drawing the ROIs, the channel having
markers was hidden using the “channel tool” to avoid any visual bias. The nucleus
for which the boundary is not clear (overlapping with each other) was not scored.
After completion of marking the ROIs using the DAPI channel, the marker
channel was turned on and from this channel, “mean grey values” and “area” were
measured using the “measure” option in the ROI manager. Our results are
consistent with a recent study that examined the subcellular localization of βCatenin and reported a substantial cytoplasmic component even when the nuclear
accumulation is increased upon Wnt activation65.
For cell counts (Fig. 3e; Fig. 4c and e; Supplementary Fig. S4b, c, and d; Fig. 5d)
“cell counter” plugin in Fiji was used. Cells for which the boundary was not
adequately resolved were excluded. While scoring for DAPI + or AI9 + cells, the
channel containing the marker was hidden using the “channel tool” to avoid any

RNA sequencing, library preparation, and analysis of mouse tissues. The
mouse ChP was dissected from E14.5 control and β-catenin GOF brains and stored
in TrizolⓇ reagent. Extracted RNA of 1 μg (RIN > 7.5, measured using the Agilent
2100 bioanalyzer) from ChPe dissected from 4 embryos was pooled for each of two
biological replicates. After library preparation, sequencing was performed on the
Illumina platform to achieve 100 bp or 150 bp reads to generate 30 Million pairedend reads per sample. FastQ QC was performed as described in67, and reads > 30
Phred scores were aligned using HISAT268. Feature counts were used to quantify
the number of reads per transcript. Differential expression analysis was performed
using DESeq2 v3.1469 on the R platform (v3.6.3). Genes showing |log2 Fold
change | ≥1 were used for further analysis. Gene ontology analysis was performed
using geneontology.org or gproﬁler.org. Semantics were summarized using
“REVIGO”70, and bar plots were created with GraphPad Prism V9.1.0. Heat maps
and sample correlation plots were plotted using R studio. Gene-based heatmaps
were plotted using normalized reads on Morpheus (Morpheus, https://
software.broadinstitute.org/morpheus).
RNA sequencing, library preparation, and analysis of organoids. Organoids
generated in Figs. 9 and 10 were pooled such that for one biological replicate, 3
organoids were used, and three such biological replicates were performed for day
18 and day 30 organoids. Bulk MARS-seq libraries were produced from 50 ng of
total RNA as previously described71. Libraries were then sequenced with 75 bp
single-end read on Illumina Nextseq500 platform, and FASTQ ﬁles were processed
and analyzed using UTAP72. Brieﬂy, sequenced reads were trimmed using cutadapt
(parameters: -a adaptor -a “A {10}” –times 2 -u 3 -u -3 -q 20 -m 25) and were
mapped to hg38 indexed reference genome using STAR73 v2.4.2a with the following parameters: –alignEndsType EndToEnd, –out Filter Mismatch Nover Lmax
0.05, –two pass Mode Basic). UMIs were counted after marking duplicates using
HTSeq-count in union mode. For the number of reads per gene, 1000 bp of 3′ end
Gencode annotated transcripts were counted. The total RNA-seq from 3 μM and
12 μM CHIR-treated organoids (Fig. 10) were done using TruSeq stranded mRNA
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library kit and sequenced by DNA Link Sequencing Lab, Korea, on NovaSeq 6000,
100PE. Data were analyzed with the UTAP pipeline71, where adapter trimming and
reference genome alignment were performed as described above. Read count per
gene was done with STAR. Normalization of the counts and differential expression
analysis was performed using DESeq2 (v3.14)69 with the parameters: betaPrior=True, cooks Cutoff=FALSE, independentFiltering=FALSE. Raw P values
were adjusted for multiple testing using the procedure of Benjamini and Hochberg.
Genes with log2FC > 1 or <−1, p adjust < 0.05 and baseMean > 10 were considered
as differentially expressed. GO Biological process overrepresentation test on differentially expressed genes between different time points of organoid growth was
performed with the package clusterProﬁler74.
qPCR Analysis
Mouse. ChP samples from control and Lmx1aCre::β-catenin GOF E14.5 embryos
were collected in a 1.5 ml tube with 200 μl of Trizol reagent. ChP from 2 brains
were pooled together and considered 1 biological replicate and 3 such biological
replicates were performed. Total RNA was extracted using Trizol reagent following
the manufacturer’s protocol. RNA concentration was measured using RNA-HS
assay kit (catalog # Q32852) in QBIT-2 ﬂuorometer (catalog # Q32866). cDNA was
synthesized using SuperScript™ IV kit (catalog # 18091050). Real-Time qPCR
reactions were performed in triplicates using KAPA SYBR FAST qPCR Kit (2X)
(catalog # KK4601) on LightCycler® 96 Real-time PCR system following the
manufacturer’s recommendation. For each primer, the annealing temperature and
primer concentration was optimized using gradient PCR. Melt curve analysis was
performed to rule out the possibility of nonspeciﬁc ampliﬁcation. GAPDH was
used as a reference gene, and analysis was performed using the ΔΔ threshold cycle
(Ct) method. The fold changes were represented as mean ± SEM.
Primers. Axin2, FP: 5′-GAAGAAATTCCATACAGGAGGAT-3′; RP: 5′-GTCACT
CGCCTTCTTGAAATAA-3; Lef1, FP: 5′-AGAAATGAGAGCGAATGTCGTA
G-3′; RP: 5′-CTTTGCACGTTGGGAAGGA-3′; Aqp1, FP: 5′-CTGCTGGCGAT
TGACTACACTG-3′; RP: 5′-GGTTTGAGAAGTTGCGGGTGAG-3′; Otx2, FP: 5′CAAAGTGAGACCTGCCAAAAAGA-3′; RP: 5′-TGGACAAGGGATCTGACA
GTG-3′; Slc12a2, FP: 5′-GCAAGACTCCAACTCAGCCAC-3′; RP: 5′-ACCTCCAT
CATCAAAAAGCCACC-3′; Slc12a4, FP: 5′-GCCCCAACCTTACTGCTGAC-3′;
RP: 5′-TCTCCTTTAGGCCGAGGGTG -3′; Slc4a10, FP: 5′-TTCAAGACCAGCC
GCTATTT-3′; RP: 5′-GGATCCCAATGGCATAGTCA-3′; Slc4a2, FP: 5′-TCCA
GAGCGAGCGGGTTATG-3′, RP: 5′-GAGGACTGGCGGTGGTACTCAAAGT
C-3′; Ttr, FP: 5′-CCGTGTTAGCAGCTCAGGAA-3′; RP: 5′-GGGTTTTAGGA
GCAGGGGAG-3′; Gapdh, FP: 5′-ATTCAACGGCACAGTCAAGG -3′; 5′-TGGA
TGCAGGGATGATGTTC-3′.
Organoids. Total RNA of Day 18 and Day 30 organoids was extracted using the
RNeasy Mini kit (Qiagen, Germany) following the manufacturer’s protocol and
followed by DNAse I treatment. RNA concentration was measured using Nanodrop (Thermo Scientiﬁc, MA, USA). cDNA was synthesized using M-MLV reverse
transcriptase (M3682, Promega, Wisconsin, USA). Real-Time reactions were performed in triplicates using KAPA SYBR FAST qPCR Kit (2X) on QuantStudio 5
Real-time PCR system (Bio-Rad, CA, USA) following the manufacturer’s recommendation. Expression levels were normalized against GAPDH using the ΔΔ
threshold cycle (Ct) method. The fold changes were represented as mean ± SEM.
Primers: AQP1, FP: 5′-TGGACACCTCCTGGCTATTG-3′; RP: 5′-GGGCCAGGA
TGAAGTCGTAG-3′; LEF1, FP: 5′-AGAACACCCCGATGACGGA-3′; RP: 5′-GA
GGGTCCCTTGTTGTAGAGG-3′; TTR, FP: 5′ ATCCAAGTGTCCTCTGATGGT
3′; RP: 5′ GCCAAGTGCCTTCCAGTAAGA 3′; OTX2, FP: 5′-AGAGGACGACGT
TCACTCG-3′; RP: 5′-TCGGGCAAGTTGATTTTCAGT-3′.
Statistics and reproducibility. Biological replicates (n) denote samples obtained
from individual brains/ organoids. The total numbers of embryos/ brains analyzed
for immunohistochemistry or in situ hybridization for each genotype were: 69
Control brains (Figs. 1–6),10 Lmx1aCre::β-catenin LOF brains (Supplementary
Fig. S2 and 3), 46 Lmx1aCre::β-catenin GOF brains (Figs. 2,3,4,6 and 7; Supplementary Fig. S3,4,5,6 and 7), 7 Foxj1Cre::β-catenin GOF brains (Fig. 5 and Supplementary Fig. S5). Detailed information about biological replicates and sample
size were described in the corresponding ﬁgure legends. For Fig. 1a–g Representative images are shown from different sections taken from 1 fetal brain at each
age (GW11 & 13). For Fig. 4f–I; 6h–m representative images are shown from 3
biologically independent replicates and the quantiﬁcation is shown from one
biological replicate for best representation purposes. For qPCR and RNAseq, each
biological replicate consisted of samples pooled from more than one brains that
were processed as one sample. For qPCR (Figs. 2 and 3), samples from 2 brains
were pooled, while for RNA Seq (Figs. 2 and 7, 8 Supplementary Fig. S8), samples
from 4 brains were pooled and considered one biological replicate. For organoids,
one organoid was an independent biological replicate. A total of 48 control organoids (3 μM CHIR) were used for Fig. 9. For Fig. 10 and Supplementary Fig. S10,
14 organoids (3 μM CHIR), 9 organoids (6 μM CHIR), 5 organoids (9 μM CHIRtreated), and 14 organoids (12 μM CHIR treated), were used for immunohistochemistry analysis. For RNA-Seq experiments (Figs. 9 & 10), 3 organoids (per
treatment condition) are pooled as one biological replicate. All replicates were
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successful and no data were excluded. The mouse genotypes could be distinguished
by apparent phenotypic features, so it was not possible to perform the quantiﬁcations in a blinded manner. During image analysis, stringent measures were
followed to avoid bias as described in the “Image analysis” section. All statistical
analysis was performed in Graph Pad Prism (V7.0 & V9.1.0), the exact test and “Pvalue” information were provided in corresponding ﬁgure legends and Source data
ﬁle. For all statistical tests conﬁdence interval is always 95% (α = 0.05). For all the
bar graphs and scatterplots error bars indicate “standard error of mean”. For all
violin plots Solid black line represents median and dotted lines represents quartiles.
Reporting Summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
The mouse RNA-seq data (Figs. 2,7,8, Supplementary Figure S1& 8) generated in this
study have been deposited in the GEO database under accession code: “GSE162784”. The
organoid MARS-seq and RNA-seq datasets (Figs. 9,10, Supplementary Fig. S9) have been
deposited in the GEO database under accession code “GSE162808”. All other relevant
data supporting the key ﬁndings of this study are available within the article and its
Supplementary Information ﬁles or from the corresponding author upon reasonable
request. Source data are provided with this paper.

Code availability
All the codes used for analysis were published previously (cited and mentioned in details
in “methods” section). All codes are available on request with the corresponding author.
The source code for UTAP software used in this manuscript for the analysis of MARSseq and RNA-seq data (Fig. 9, 10) is available at https://bitbucket.org/bbcu/utap.
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